Metabolic dysfunction-associated steatohepatitis-related liver cancer

1. Metabolic dysfunction-associated steatohepatitis-related liver cancer is associated with SOD2, ALDH2, MME and IGFBP1 expression in silico.

   “SOD2, ALDH2, MME and IGFBP1 which were belonged to SAGs were differential expressed in MRLC compared to paracancerous”

   In silicocompared with paracancerous tissueliver

   Multi omics analysis reveals senescence associated genes in metabolic dysfunction associated steatohepatitis related liver cancer and their functional validation

   International journal of biological macromolecules·Mar 31, 2026

More on SOD2, ALDH2, MME and IGFBP1 expression